Ibrahima Soumaoro

Ibrahima Soumaoro

Genmab - Copenhagen / Denmark
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 4970998
person_outline Ibrahima Soumaoro's MOST POPULAR ARTICLES
1-) Safety and efficacy of nivolumab monotherapy in recurrent or metastatic cervical, vaginal, or vulvar carcinoma: results from the phase I/II CheckMate 358 trial Journal of Clinical Oncology 37 (31), 2825-2834, 2019
2-) Abstract CT074: Non-comparative, open-label, multiple cohort, phase 1/2 study to evaluate nivolumab (NIVO) in patients with virus-associated tumors (CheckMate 358): Efficacy … Cancer Research 77 (13_Supplement), CT074-CT074, 2017
3-) An open-label, multicohort, phase 1/2 study in patients with virus-associated cancers (CheckMate 358): safety and efficacy of neoadjuvant nivolumab in squamous cell carcinoma … Annals of oncology 28, v628-v629, 2017
4-) Non-comparative, open-label, multiple cohort, phase 1/2 study to evaluate nivolumab (NIVO) in patients with virus-associated tumors (CheckMate 358): efficacy and safety in …SL Topalian, S Bhatia, A Hollebecque, A Awada, JP De Boer, ...Cancer Research 77, 2017762017
5-) An open-label, multicohort, phase 1/2 study in patients with virus-associated cancers (CheckMate 358): safety and efficacy of neoadjuvant nivolumab in squamous cell carcinoma …RL Ferris, A Gonçalves, SS Baxi, UM Martens, H Gauthier, M Langenberg, ...Annals of oncology 28, v628-v629, 2017